Skip to main content
logo
  • Investment Strategies
    Overview

    Investment Options

    • Alternatives
    • Beta Strategies
    • Equities
    • Fixed Income
    • Global Liquidity
    • Multi-Asset Solutions

    Capabilities & Solutions

    • ETFs
    • Pension Strategy & Analytics
    • Global Insurance Solutions
    • Outsourced CIO
    • Sustainable investing
  • Insights
    Overview

    Market Insights

    • Market Insights Overview
    • Eye on the Market
    • Guide to the Markets
    • Guide to Alternatives
    • Market Updates
    • Guide to Investing in Asia
    • U.S. Policy Pulse Hub

    Portfolio Insights

    • Portfolio Insights Overview
    • Alternatives
    • Asset Class Views
    • Currency
    • Equity
    • ETF Perspectives
    • Fixed Income
    • Long-Term Capital Market Assumptions
    • Sustainable Investing
    • Strategic Investment Advisory Group

    ETF Insights

    • ETF Insights overview
    • Guide to ETFs
    • ETF Perspectives
  • Resources
    Overview
    • Center for Investment Excellence Podcasts
    • Insights App
    • Library
    • Webcasts
    • Multimedia
    • Morgan Institutional
    • Investment Academy
  • About us
    Overview
    • Spectrum: Our Investment Platform
    • Our Leadership Team
  • Contact Us
  • English
  • Role
  • Country
Morgan Institutional
Search
Menu
Search
You are about to leave the site Close
J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
CONTINUE Go Back
  1. The equity rally and herd immunity

  • LinkedIn Twitter Facebook

The equity rally and herd immunity

13/04/2020

Michael Cembalest

After the equity rally, P/E multiples are back at around 16x 2021 consensus earnings; any advances from here are probably much less one-directional given what still lies ahead, even after $8 trillion in asset purchases, loan guarantees and direct lending from the Federal Reserve.  In Europe, the latest antibody tests show large numbers of unreported infections, which could signal an earlier increase of herd immunity than you might think.

Continue reading

LISTEN AND SUBSCRIBE TO MICHAEL CEMBALEST

In this podcast series, Michael Cembalest, Chairman of Market and Investment Strategy offers timely commentary on the economy, marekts and investment portfolios
 

Listen on Apple Podcasts

Subscribe to RSS Feed

Read more by michael cembalest

903c02a82872c26

  • Markets
  • Economy
  • Eye on the Market
J.P. Morgan Asset Management

  • About us
  • Investment stewardship
  • Privacy policy
  • Cookie policy
  • Complaint Resolution
  • Sitemap
J.P. Morgan

  • J.P. Morgan
  • JPMorgan Chase
  • Chase

READ IMPORTANT LEGAL INFORMATION. CLICK HERE >

The value of investments may go down as well as up and investors may not get back the full amount invested.

Copyright 2025 JPMorgan Chase & Co. All rights reserved.